City

Moscow (2)

Halifax (1)

Helsingborg (1)

Kristianstad (1)

Lund (1)

Malmo (1)

Miami (1)

Nizhny Novgorod (1)

Overall Status

Recruiting (3)

Not yet recruiting (1)

Suspended (1)

Withdrawn (1)

Phase

n/a (2)

phase 3 (1)

Sponsor

MelanomaPRO, Russia (2)

Carman Giacomantonio (1)

Peking University (1)

Region Skane (1)

University of Miami (1)

Collaborator

Nova Scotia Health Authority (1)

Privolzhsky Research Medical University (1)

University of Miami Sylvester Comprehensive Cancer Center (1)

Intervention

aldesleukin (1)

h&e (1)

if cocktail (1)

if mart-1 (1)

ihc mart-1 (1)

imaging (1)

mobile phone application "prorodinki" (1)

saline (1)

surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines (1)

Study Documents

Intervention Type

other (2)

biological (1)

diagnostic test (1)

drug (1)

procedure (1)

Funder Type

Other (6)

Study Type

Interventional (3)

Observational (3)

melanoma in situ

Showing 1 - 6 of 6

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

BioMEL- Diagnostic and Prognostic Factors in Melanoma.

Recruiting

Melanoma
+5 more

Imaging

Helsingborg, Skane, Sweden
+3 more

Sep 1, 2022

Melanoma (Skin), Melanoma in Situ Trial in Halifax (Aldesleukin, Saline)

Suspended

Melanoma (Skin)
Melanoma in Situ

Aldesleukin
Saline

Halifax, Nova Scotia, Canada

Queen Elizabeth II Health Sciences Centre

Jul 18, 2022

Patients With Stage 0-IV Melanoma in Real Clinical Practice

Recruiting

Melanoma
+7 more

surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines